• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠疫情期间新诊断的糖尿病:新的大流行——文献综述

Newly Diagnosed Diabetes Mellitus During COVID-19: The New Pandemic - A Literature Review.

作者信息

Knebusch Toriello Nicole, Prato Alterio Natalia María, Ramírez Villeda Lourdes María

机构信息

Baccalaureus Scientiae in Clinical Nutrition, Guatemala, Guatemala.

出版信息

Curr Trop Med Rep. 2022;9(4):250-256. doi: 10.1007/s40475-022-00268-3. Epub 2022 Sep 26.

DOI:10.1007/s40475-022-00268-3
PMID:36187907
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9510456/
Abstract

PURPOSE OF REVIEW

Coronavirus disease 2019 (COVID-19) has caused a spike in newly diagnosed diabetes mellitus (NDDM). NDDM and COVID-19 infection are not well established as a cause-and-effect relationship; hence, the present review aims to define the underlying causes and consequences of COVID-19 infection in relation to the condition.

RECENT FINDINGS

β-Cells are infiltrated by SARS-CoV-2, causing glycometabolic dysfunction and insulin dysregulation. The disease causes systemic inflammation and pro-inflammatory cytokines, as well as hormonal changes that lead to insulin resistance and hyperglycemia that are difficult to manage. As a result of NDDM, complications related to COVID-19 infection become more severe.

SUMMARY

NDDM related to COVID-19 infection complicates hospitalization outcomes and adversely affects quality of life in patients. There are many possible causes and consequences associated with NDDM, but for establishing preventive measures and treatments for NDDM, more evidence regarding its epidemiology, physiopathology, etiology, and nutritional aspects is required.

摘要

综述目的

2019年冠状病毒病(COVID-19)导致新诊断糖尿病(NDDM)病例激增。NDDM与COVID-19感染之间的因果关系尚未明确确立;因此,本综述旨在明确COVID-19感染与该病症相关的潜在原因和后果。

最新发现

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)侵袭β细胞,导致糖代谢功能障碍和胰岛素调节异常。该疾病引发全身炎症和促炎细胞因子,以及导致胰岛素抵抗和难以控制的高血糖的激素变化。由于NDDM,与COVID-19感染相关的并发症变得更加严重。

总结

与COVID-19感染相关的NDDM使住院结局复杂化,并对患者的生活质量产生不利影响。NDDM存在许多可能的原因和后果,但为了制定NDDM的预防措施和治疗方法,需要更多关于其流行病学、生理病理学、病因学和营养方面的证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e444/9510456/6494cb059262/40475_2022_268_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e444/9510456/6494cb059262/40475_2022_268_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e444/9510456/6494cb059262/40475_2022_268_Fig1_HTML.jpg

相似文献

1
Newly Diagnosed Diabetes Mellitus During COVID-19: The New Pandemic - A Literature Review.新冠疫情期间新诊断的糖尿病:新的大流行——文献综述
Curr Trop Med Rep. 2022;9(4):250-256. doi: 10.1007/s40475-022-00268-3. Epub 2022 Sep 26.
2
Newly diagnosed diabetes vs. pre-existing diabetes upon admission for COVID-19: Associated factors, short-term outcomes, and long-term glycemic phenotypes.新诊断的糖尿病与 COVID-19 入院时的既有糖尿病:相关因素、短期结局和长期血糖表型。
J Diabetes Complications. 2022 Apr;36(4):108145. doi: 10.1016/j.jdiacomp.2022.108145. Epub 2022 Feb 4.
3
Acute Stroke Patients with Newly Diagnosed Diabetes Mellitus Have Poorer Outcomes than Those with Previously Diagnosed Diabetes Mellitus.新诊断为糖尿病的急性卒中患者比先前已诊断为糖尿病的患者预后更差。
J Stroke Cerebrovasc Dis. 2018 Sep;27(9):2327-2335. doi: 10.1016/j.jstrokecerebrovasdis.2018.04.017. Epub 2018 May 18.
4
Prognosis of Intracerebral Hemorrhage with Newly Diagnosed Diabetes Mellitus According to Hemoglobin A1c Criteria.根据糖化血红蛋白标准评估新诊断糖尿病患者脑出血的预后
J Stroke Cerebrovasc Dis. 2018 May;27(5):1127-1133. doi: 10.1016/j.jstrokecerebrovasdis.2017.11.019. Epub 2018 Feb 19.
5
Prognosis of Ischemic Stroke With Newly Diagnosed Diabetes Mellitus According to Hemoglobin A1c Criteria in Chinese Population.中国人群中根据糖化血红蛋白标准诊断的新发糖尿病合并缺血性卒中的预后
Stroke. 2016 Aug;47(8):2038-44. doi: 10.1161/STROKEAHA.116.013606. Epub 2016 Jul 5.
6
Diabetes mellitus and COVID-19: Understanding the association in light of current evidence.糖尿病与2019冠状病毒病:基于当前证据理解两者之间的关联。
World J Clin Cases. 2021 Oct 6;9(28):8327-8339. doi: 10.12998/wjcc.v9.i28.8327.
7
COVID-19 associated diabetes mellitus: A review.新型冠状病毒肺炎相关糖尿病:综述
World J Diabetes. 2022 Sep 15;13(9):729-737. doi: 10.4239/wjd.v13.i9.729.
8
Diabetic Ketoacidosis and COVID-19: A Retrospective Observational Study.糖尿病酮症酸中毒与2019冠状病毒病:一项回顾性观察研究。
Cureus. 2022 Oct 31;14(10):e30895. doi: 10.7759/cureus.30895. eCollection 2022 Oct.
9
Identical anthropometric characteristics of impaired fasting glucose combined with impaired glucose tolerance and newly diagnosed type 2 diabetes: anthropometric indicators to predict hyperglycaemia in a community-based prospective cohort study in southwest China.空腹血糖受损合并糖调节受损及新诊断 2 型糖尿病患者的人体测量学特征:基于社区的前瞻性队列研究中预测中国西南地区人群高血糖的人体测量学指标。
BMJ Open. 2018 May 9;8(5):e019735. doi: 10.1136/bmjopen-2017-019735.
10
COVID-19: Diabetes Perspective-Pathophysiology and Management.2019冠状病毒病:糖尿病视角——病理生理学与管理
Pathogens. 2023 Jan 25;12(2):184. doi: 10.3390/pathogens12020184.

引用本文的文献

1
Hyperglycemia, diabetes, and de novo diabetes in patients hospitalized in intensive care units for COVID-19 in Colombia: Results from a longitudinal cohort study.哥伦比亚新冠肺炎重症监护病房住院患者的高血糖、糖尿病和新发糖尿病:一项纵向队列研究的结果
J Crit Care Med (Targu Mures). 2025 Jul 31;11(3):257-264. doi: 10.2478/jccm-2025-0026. eCollection 2025 Jul.
2
Risk for Newly Diagnosed Type 2 Diabetes Mellitus after COVID-19 among Korean Adults: A Nationwide Matched Cohort Study.新冠疫情后韩国成年人新发 2 型糖尿病风险:一项全国匹配队列研究。
Endocrinol Metab (Seoul). 2023 Apr;38(2):245-252. doi: 10.3803/EnM.2023.1662. Epub 2023 Apr 5.

本文引用的文献

1
Risk of incident diabetes post-COVID-19: A systematic review and meta-analysis.新冠疫情后发生糖尿病的风险:系统评价和荟萃分析。
Prim Care Diabetes. 2022 Aug;16(4):591-593. doi: 10.1016/j.pcd.2022.05.009. Epub 2022 May 30.
2
Risks and burdens of incident diabetes in long COVID: a cohort study.长期新冠患者新发糖尿病的风险与负担:一项队列研究。
Lancet Diabetes Endocrinol. 2022 May;10(5):311-321. doi: 10.1016/S2213-8587(22)00044-4. Epub 2022 Mar 21.
3
Newly diagnosed diabetes vs. pre-existing diabetes upon admission for COVID-19: Associated factors, short-term outcomes, and long-term glycemic phenotypes.
新诊断的糖尿病与 COVID-19 入院时的既有糖尿病:相关因素、短期结局和长期血糖表型。
J Diabetes Complications. 2022 Apr;36(4):108145. doi: 10.1016/j.jdiacomp.2022.108145. Epub 2022 Feb 4.
4
Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis.不同随访期的新冠后综合征症状的流行率:系统评价和荟萃分析。
Clin Microbiol Infect. 2022 May;28(5):657-666. doi: 10.1016/j.cmi.2022.01.014. Epub 2022 Feb 3.
5
Alterations in cortisol and interleukin-6 secretion in patients with COVID-19 suggestive of neuroendocrine-immune adaptations.COVID-19 患者皮质醇和白细胞介素-6 分泌的改变提示神经内分泌-免疫适应。
Endocrine. 2022 Feb;75(2):317-327. doi: 10.1007/s12020-021-02968-8. Epub 2022 Jan 18.
6
Interrelationship between 2019-nCov receptor DPP4 and diabetes mellitus targets based on protein interaction network.基于蛋白质相互作用网络的 2019-nCov 受体 DPP4 与糖尿病靶点的相互关系。
Sci Rep. 2022 Jan 7;12(1):188. doi: 10.1038/s41598-021-03912-6.
7
Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2.急性新冠肺炎中的高血糖症表现为胰岛素抵抗以及严重急性呼吸综合征冠状病毒2对脂肪组织的感染性。
Cell Metab. 2021 Nov 2;33(11):2174-2188.e5. doi: 10.1016/j.cmet.2021.09.009. Epub 2021 Sep 16.
8
Adiponectin to leptin ratio reflects inflammatory burden and survival in COVID-19.脂联素与瘦素比值反映 COVID-19 中的炎症负担和生存状况。
Diabetes Metab. 2021 Nov;47(6):101268. doi: 10.1016/j.diabet.2021.101268. Epub 2021 Jul 29.
9
Daily glucose variation influenced by the use of corticosteroids in COVID-19 patients treated in Lima-Peru.在秘鲁利马接受治疗的 COVID-19 患者中,糖皮质激素的使用会影响日常血糖波动。
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102188. doi: 10.1016/j.dsx.2021.102188. Epub 2021 Jun 29.
10
Long-Term Outcomes of Patients with Coronavirus Disease 2019 at One Year after Hospital Discharge.2019冠状病毒病患者出院一年后的长期预后
J Clin Med. 2021 Jun 30;10(13):2945. doi: 10.3390/jcm10132945.